CCEL

Cryo-Cell International, Inc. (NASDAQ:CCEL) is a pioneering biotechnology company founded in 1989 and headquartered in Oldsmar, Florida. The company went public in 1994 and has established itself as a leader in the cellular processing and cryogenic storage industry, specifically focusing on umbilical cord blood and tissue preservation. With approximately 500,000 cord blood and cord tissue stem cell units stored worldwide, Cryo-Cell has built one of the largest private cord blood banks globally, serving families who seek to preserve their newborn's stem cells for potential future medical treatments.